25 Years Of Practice

PPA Multidistrict Litigation (Dxatrim)

Goldenberg Schneider successfully represented a woman who suffered a stroke in 1985 while taking Dexatrim. The link between Dexatrim’s active ingredient (PPA) and its propensity to cause strokes was made public in 2000. Overcoming substantial litigation hurdles including the defendant’s statute of repose argument, the Firm recovered over $1.5 million for this client.

Go Back